These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21717898)
1. Screening for prostate cancer with PSA testing: current status and future directions. Croswell JM; Kramer BS; Crawford ED Oncology (Williston Park); 2011 May; 25(6):452-60, 463. PubMed ID: 21717898 [TBL] [Abstract][Full Text] [Related]
2. Early detection, PSA screening, and management of overdiagnosis. Borza T; Konijeti R; Kibel AS Hematol Oncol Clin North Am; 2013 Dec; 27(6):1091-110, vii. PubMed ID: 24188254 [TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Screening and the Associated Controversy. Tabayoyong W; Abouassaly R Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521 [TBL] [Abstract][Full Text] [Related]
4. [Focus on the screening for prostate cancer by PSA]. Roumeguère T; Van Velthoven R Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen screening for prostate cancer in older men in the United States of America. Black A; Berg CD Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians. Kell JS Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer. Payne H; Cornford P Urol Oncol; 2011; 29(6):593-601. PubMed ID: 20060331 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: measuring PSA. Pezaro C; Woo HH; Davis ID Intern Med J; 2014 May; 44(5):433-40. PubMed ID: 24816306 [TBL] [Abstract][Full Text] [Related]
13. PSA in screening for prostate cancer: more good than harm or more harm than good? Duffy MJ Adv Clin Chem; 2014; 66():1-23. PubMed ID: 25344984 [TBL] [Abstract][Full Text] [Related]
14. Prostate specific antigen best practice statement: 2009 update. Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P; J Urol; 2013 Jan; 189(1 Suppl):S2-S11. PubMed ID: 23234625 [TBL] [Abstract][Full Text] [Related]
15. Unravelling the prostate-specific antigen controversy: a West of Scotland perspective. Zafar N; Miller S; Leburn V; Qureshi KN; Rajan P Scott Med J; 2014 May; 59(2):126-9. PubMed ID: 24682103 [TBL] [Abstract][Full Text] [Related]
17. PSA-based screening for prostate cancer. Too many adverse effects. Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259 [TBL] [Abstract][Full Text] [Related]
18. [Screening for prostate cancer: an up date]. Ito K Gan To Kagaku Ryoho; 2012 Jan; 39(1):33-7. PubMed ID: 22241351 [TBL] [Abstract][Full Text] [Related]
19. [Screening for prostate cancer: present status and future perspectives]. Ito K Nihon Rinsho; 2014 Dec; 72(12):2198-203. PubMed ID: 25518358 [TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer: the current evidence and guidelines controversy. Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]